Harmut Lode
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Nosocomial Infections in ICU
Papers in
- Pharmacology 33
- Antibiotics Pharmacokinetics and Efficacy 31
- Pharmacogenetics and Drug Metabolism 4
-
- Antibiotic Resistance in Bacteria 15
- Co-authors
- P. Koeppe (12 shared papers)K. Börner (8 shared papers)Santiago Ewig (1 shared paper)Antoní Torres (1 shared paper)Jean M. Carlet (1 shared paper)G. Höffken (7 shared papers)Peter Olschewski (2 shared papers)Javier Garau (2 shared papers)
- Journals
- Infection (7 papers)Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (4 papers)International Journal of Antimicrobial Agents (3 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Harmut Lode
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 102
- Molecular Medicine 384
- Critical Care and Intensive Care Medicine 251
- Applied Microbiology and Biotechnology 81
- Pharmacology 628
- Clinical Biochemistry 137
Countries citing papers authored by Harmut Lode
This map shows the geographic impact of Harmut Lode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmut Lode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmut Lode more than expected).
Fields of papers citing papers by Harmut Lode
This network shows the impact of papers produced by Harmut Lode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmut Lode. The network helps show where Harmut Lode may publish in the future.
Co-authors
The 25 scholars most cited alongside Harmut Lode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 226 | |
| 2 | 1998 | 198 | |
| 3 | 1997 | 142 | |
| 4 | 1987 | 139 | |
| 5 | 1992 | 113 | |
| 6 | 1999 | 104 | |
| 7 | 1991 | 86 | |
| 8 | 1984 | 69 | |
| 9 | 1997 | 51 | |
| 10 | 1987 | 50 | |
| 11 | 1976 | 36 | |
| 12 | 1974 | 34 | |
| 13 | 2000 | 28 | |
| 14 | 2004 | 24 | |
| 15 | 1995 | 23 | |
| 16 | 1977 | 22 | |
| 17 | 1983 | 20 | |
| 18 | 2003 | 17 | |
| 19 | 1988 | 16 | |
| 20 | 2018 | 14 |
About Harmut Lode
Harmut Lode is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Epidemiology and Pharmacology, having authored 53 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Antibiotic Resistance in Bacteria (15 papers), Pneumonia and Respiratory Infections (12 papers), Antifungal resistance and susceptibility (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Molecular Medicine (384 citations), Critical Care and Intensive Care Medicine (251 citations), Applied Microbiology and Biotechnology (81 citations), Pharmacology (628 citations) and Clinical Biochemistry (137 citations). Harmut Lode has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include P. Koeppe, K. Börner, Santiago Ewig, Antoní Torres, Jean M. Carlet, G. Höffken, Peter Olschewski, Javier Garau, John S. Bradley and John Peter Quinn. Their work appears in journals such as Infection, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.